Communiqués Arcellx, Inc.

Actions

ACLX

US03940C1009

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 11/06/2024			Varia. 5j.	Varia. 1 janv.
54 ^USD	-0,24 %		+4,43 %	-2,70 %

31/05	ARCELLX, INC. : Opinion positive de Piper Sandler	ZM
15/05	ARCELLX, INC. : Opinion positive de Stifel Nicolaus	ZM

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Arcellx : IMMagine-3 Multi-center, Global, Phase 3 Randomized Control Clinical Trial Design	10/05	PU
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program	09/05	BU
Arcellx Provides First Quarter 2024 Financial Results	09/05	BU
Arcellx to Participate in Two Upcoming Investor Conferences	07/05	BU
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference	04/04	BU
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	20/03	BU
Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference	29/02	PR
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights	28/02	PR
Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH	11/12	AQ
Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and Exposition	03/11	AQ
Arcellx : November 2023 Corporate Presentation	01/11	PU
Arcellx to Participate in Two Upcoming Investor Conferences	26/10/23	PR
Arcellx : September 2023 Corporate Presentation	01/09/23	PU
Arcellx : August 2023 Corporate Presentation	15/08/23	PU
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results	14/08/23	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	17/07/23	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	12/07/23	PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	03/07/23	PR
Arcellx : Corporate Presentation July 2023	29/06/23	PU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX	24/06/23	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Arcellx, Inc.

Actions

ACLX

US03940C1009

Communiqués

Filtres